Top Markets
#1 Ontology Gas Ontology Gas +30.80%
#2 EXOD EXOD +22.08%
#3 Status Status +21.90%
#4 ETHGas ETHGas +19.74%
#5 The Black Bull The Black Bull +17.98%
#6 Anvil Anvil +12.83%
#7 Fake World Assets Fake World Assets +10.94%
#8 aelf aelf +9.61%
#9 Gas Gas +9.27%
#10 Derive Derive +8.79%
Coin of the day
Ontology Gas Ontology Gas
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
AlloVir, Inc. AlloVir, Inc.

AlloVir, Inc.

ALVR
Classifica tra le azioni #25523
AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to... AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to researching and developing allogeneic, "off-the-shelf" multi-virus specific T-cell (VST) therapies. Its primary goal is to prevent and treat severe diseases caused by viral infections. The company's lead product, posoleucel, is an allogeneic, ready-to-use VST therapy designed to combat several significant viruses, including BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Beyond this flagship candidate, AlloVir's pipeline features additional investigational treatments in various stages of development. These include ALVR106, which targets respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109, developed to address SARS-CoV-2 and COVID-19; ALVR107, for treating hepatitis B; and ALVR108. Established in 2013, the company was initially known as ViraCyte, Inc. before officially rebranding as AlloVir, Inc. in May 2019. Its headquarters are located in Waltham, Massachusetts.
Prezzo delle azioni
$9.81
Ultima sincronizzazione: 2025-03-18
Capitalizzazione di mercato
$48.68M
Variazione (1 giorno)
1.55%
Variazione (1 anno)
0.00%
Paese
US
Scambia AlloVir, Inc. (ALVR)

Categoria

Healthcare
EPS per AlloVir, Inc. (ALVR)
EPS al June 2026 TTM: $-1.71
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di AlloVir, Inc., l’EPS attuale della società (TTM) è $-1.71. Alla fine del 2023, la società aveva un EPS di $-42.09 una diminuzione rispetto a rispetto a quello del 2022, che era di $-50.60.
Storico EPS per AlloVir, Inc. da 2018 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) $-1.71 -85.42%
2024 $-11.73 -72.13%
2023 $-42.09 -16.82%
2022 $-50.60 -19.71%
2021 $-63.02 5.79%
2020 $-59.57 354.39%
2019 $-13.11 71,150.00%
2018 $-0.02 0.00%
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -1,112.87%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -1,722.22%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -274.27%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 366.67%
US